High materiality9/10
Pyxis Oncology price target raised to $8 from $7 at H.C. Wainwright
Why it may matterVerify against the original reporting
Strong Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright increases PYXS target to $8; current price ~$3.38, indicating substantial upside potential.
- Wainwright raises target to $8; price $3.38; ~136% upside.
Key facts
- 01
Target: $8
- 02
Posted price: $3.38
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Swayampakula Ramakanth
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.